Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Redman

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Blood|January 1, 1988
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)W S Velasquez, F Cabanillas, P Salvador, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 1992
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphomaJ R Redman, F Cabanillas, W S Velasquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 1992
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failureJ A Spinolo, F Cabanillas, D O Dixon, et al.
Leukemia & Lymphoma|June 1, 1995
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinaseS Suki, F Swan, S Tucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's diseaseF B Hagemeister, L M Fuller, W S Velasquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
CHOP-Bleo plus interferon for stage IV low-grade lymphomaP McLaughlin, F Cabanillas, F B Hagemeister, et al.
Blood|August 1, 1989
Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival dataW S Velasquez, S Jagannath, S L Tucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Small noncleaved cell lymphoma in adults: superior results for stages I-III diseaseT M Lopez, F B Hagemeister, P McLaughlin, et al.
Seminars in Oncology|December 1, 1990
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's diseaseF B Hagemeister, F Cabanillas, W S Velásquez, et al.
Blood|March 1, 1991
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapyW S Velasquez, L M Fuller, S Jagannath, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Blood|January 1, 1988
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)W S Velasquez, F Cabanillas, P Salvador, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 1992
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphomaJ R Redman, F Cabanillas, W S Velasquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 1992
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failureJ A Spinolo, F Cabanillas, D O Dixon, et al.
Leukemia & Lymphoma|June 1, 1995
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinaseS Suki, F Swan, S Tucker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's diseaseF B Hagemeister, L M Fuller, W S Velasquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
CHOP-Bleo plus interferon for stage IV low-grade lymphomaP McLaughlin, F Cabanillas, F B Hagemeister, et al.
Blood|August 1, 1989
Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival dataW S Velasquez, S Jagannath, S L Tucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Small noncleaved cell lymphoma in adults: superior results for stages I-III diseaseT M Lopez, F B Hagemeister, P McLaughlin, et al.
Seminars in Oncology|December 1, 1990
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's diseaseF B Hagemeister, F Cabanillas, W S Velásquez, et al.
Blood|March 1, 1991
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapyW S Velasquez, L M Fuller, S Jagannath, et al.
Pageof 5